| |
This site is no longer actively maintained. It remains posted for archive purposes only. | | |
| Epi
and Lab Capacity Program > Home |
On this page:
Background
In 1994, CDC began working with
other federal agencies, state and local health departments,
and other partners to strengthen our nation's capacity to
recognize and respond to emerging infectious disease threats
through implementation of the CDC plan, Addressing Emerging
Infectious Disease Threats: A
Prevention Strategy for the United States.
Although this effort is well
underway, fulfilling CDC's vision of a safer world in the
next millennium requires long-term commitment and sustained
effort. The second phase of the CDC effort, Preventing
Emerging Infectious Diseases: A Strategy for the 21st Century
(available on the Internet at http://www.cdc.gov/ncidod/emergplan/),
was released in October 1998. It takes into account
recent challenges and builds on the experience, success, and
knowledge gained from the initial plan.
Purpose
The purpose of the Epidemiology
and Laboratory Capacity for Infectious Diseases (ELC) program
is to build on this effort by assisting state and eligible
local public health agencies to strengthen their basic epidemiologic
and laboratory capacity to address infectious disease threats.
Focus
The ELC program focuses on notifiable diseases, food-, water-, and vector-borne diseases, vaccine-preventable diseases, and drug-resistant infections. It is intended to support activities that enhance the ability of a program to
- identify and monitor the occurrence
of infectious diseases of public health importance in a
community
- characterize disease determinants
- identify and respond to disease
outbreaks and other infectious disease emergencies
- use public health data for
priority setting and policy development
- assess the effectiveness of
activities
Strengthening
collaboration between laboratory and epidemiology
practice is a crucial component of this program.
|
 |
ELC cooperative agreements are established in all 50 states. In addition, funding is provided for ELC programs in six large local health departments (New York City, Philadelphia, Washington, D.C., Chicago, Houston, and Los Angeles), and two territories (Puerto Rico and the Republic of Palau).
Visit the ELC References and Resources page for related links, including funding guidance attachments for Antimicrobial Resistance, Food Related Diseases, Hepatitis Prevention and Control, Influenza Surveillance and Response, National Electronic Disease Surveillance System (NEDSS), West Nile Virus, and Funding Reference documents.
View the ELC Program Announcements and Attachments page to view program announcements, including Program Announcement 04040, Program Announcement 01022, and FY 2005 Attachments.
|
